Scleroderma Research Foundation
Historical collection: May 2019 · Rating details mostly from 2017. Source & context
What this organization describes
Research is the key. By investing in the most promising, highest quality research, we will find a cure.
Mission and tagline reproduced from the source record.
Three perspectives. One record.
out of 100
out of 100
out of 100
These are the dataset’s historical numeric fields, not a current rating or a new DonorAPI.com assessment. Read the score context ↗
Revenue, expenses, and composition
Program expenses
$2,168,711.69 recorded amountFundraising expenses
$197,155.61 recorded amountAdministrative expenses
$156,713.43 recorded amount- Fundraising efficiency
- $0.06 spent per $1 raised in donations, as defined in the source.
Expense shares are displayed as percentages. Component amounts in this collection match total expenses multiplied by the source ratios; rounding can leave a small difference from the total. The source does not supply a row-specific fiscal year. Field definitions ↗
The leadership information supplied
- Recorded leader
- Amy Hewitt
- Recorded compensation
- $130,654.00
- Recorded compensation percentage
- 5.16%
These fields do not establish the current officeholder or current compensation. The metadata does not specify the denominator of the leader compensation percentage. Read with context ↗
Inspect all 23 original source fields
Exact source strings are retained below, including numeric precision. A blank value is marked as not reported; zero remains zero.
| Source field | Original source value |
|---|---|
ascoreAccountability & transparency score | 96.0 |
categoryCategory | Health |
descriptionMission & description | The Scleroderma Research Foundation (SRF) is the nation's leading nonprofit investor in medical research aimed at discovering improved therapies and, ultimately, a cure for people living with scleroderma. Founded in 1987 by patient and activist Sharon Monsky, the SRF funds and facilitates the most promising, highest quality research and works to increase awareness of this life-threatening illness. To date, the SRF has invested more than $30,000,000 in groundbreaking science at some of the world's most prestigious research institutions and continues to lead the way in the search for improved therapies and a cure. |
einEIN | 68-0087234 |
tot_expTotal expenses | 2527636.0 |
admin_exp_pAdministrative expense fraction | 0.062 |
fund_effFundraising efficiency ($ per $1 raised) | 0.06 |
fund_exp_pFundraising expense fraction | 0.078 |
program_exp_pProgram expense fraction | 0.858 |
fscoreFinancial score | 100.0 |
leaderRecorded leader | Amy Hewitt |
leader_compRecorded leader compensation | 130654.0 |
leader_comp_pRecorded leader compensation fraction | 0.0516 |
mottoTagline | Research is the key. By investing in the most promising, highest quality research, we will find a cure. |
nameCharity name | Scleroderma Research Foundation |
tot_revTotal revenue | 2880248.0 |
scoreOverall score | 97.17 |
stateState code | CA |
subcategorySubcategory | Medical Research |
sizeSource size label | small |
program_expProgram expenses | 2168711.688 |
fund_expFundraising expenses | 197155.608 |
admin_expAdministrative expenses | 156713.432 |
Source: Charity Navigator Scores Expenses Dataset, version 1, attributed to katyjqian on Kaggle. Collection: May 2019; rating details mostly from 2017. Read attribution, scope, and reuse notes.